Abstract
Recently, advances in wearable technologies, data science and machine learning have begun to transform evidence-based medicine, offering a tantalizing glimpse into a future of next-generation ‘deep’ medicine. Despite stunning advances in basic science and technology, clinical translations in major areas of medicine are lagging. While the COVID-19 pandemic exposed inherent systemic limitations of the clinical trial landscape, it also spurred some positive changes, including new trial designs and a shift toward a more patient-centric and intuitive evidence-generation system. In this Perspective, I share my heuristic vision of the future of clinical trials and evidence-based medicine.
Original language | English (US) |
---|---|
Pages (from-to) | 49-58 |
Number of pages | 10 |
Journal | Nature medicine |
Volume | 29 |
Issue number | 1 |
DOIs | |
State | Published - Jan 2023 |
ASJC Scopus subject areas
- General Biochemistry, Genetics and Molecular Biology